Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Oramed Pharmaceuticals Inc | ORMP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.20 | 04:38:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.20 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.67 - 5.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.20 | USD |
Oramed Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 89.14M | 40.52M | - | 1.63M | 5.53M | 0.14 | 16.13 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Oramed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ORMP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.59 | 2.64 | 2.14 | 2.34 | 146,540 | -0.39 | -15.06% |
| 1 Month | 2.80 | 3.14 | 2.14 | 2.62 | 129,210 | -0.60 | -21.43% |
| 3 Months | 2.28 | 3.67 | 2.14 | 2.95 | 179,616 | -0.08 | -3.51% |
| 6 Months | 2.05 | 3.67 | 1.67 | 2.47 | 191,929 | 0.15 | 7.32% |
| 1 Year | 2.25 | 5.25 | 1.67 | 3.14 | 360,053 | -0.05 | -2.22% |
| 3 Years | 8.47 | 31.54 | 1.67 | 8.49 | 701,630 | -6.27 | -74.03% |
| 5 Years | 4.00 | 31.54 | 1.67 | 8.02 | 526,643 | -1.80 | -45.00% |
Oramed Pharmaceuticals Description
| Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas. |
